Grants for Public housing authorities - Health

This funding opportunity supports researchers in developing innovative resources and technologies to improve the reliability and applicability of animal models in biomedical research, with a focus on projects that address broad health issues and involve multiple NIH Institutes.

This funding opportunity supports research on how diet and lipid metabolism influence tumor growth and progression, targeting higher education institutions, nonprofits, and certain for-profit organizations with expertise in nutrition science.

This funding opportunity provides financial support to various organizations to enhance Indonesia's public health systems and capacity through collaboration with the Ministry of Health, focusing on critical areas like surveillance, laboratory systems, and emergency response.

This grant provides funding for researchers to develop and validate innovative, safe, and noninvasive methods for real-time assessment of placenta development and function throughout pregnancy, ultimately aiming to improve maternal and fetal health outcomes.

Reissue PAR-19-220.

This program provides funding to early-career researchers who have received specific NIDDK K awards, enabling them to conduct small-scale research projects that will help them transition to independent investigator roles.

This grant provides funding for innovative research projects aimed at improving mental health services and access for underserved populations, focusing on non-clinical trial methodologies.

This funding opportunity supports early-career clinical scientists from diverse backgrounds in developing their research skills and addressing cancer health disparities through mentored research experiences in cancer-related fields.

This funding opportunity provides financial support to organizations working in Tanzania to improve HIV prevention and treatment services, strengthen local health systems, and promote health equity for people living with HIV.

This grant provides funding to support advanced students and postdoctoral researchers in neuroscience, helping them gain the skills needed to translate basic research into clinical applications for neurological diseases.

This funding opportunity supports research projects that evaluate and improve crisis response services for suicide prevention, targeting a wide range of eligible applicants including universities, nonprofits, and government entities.

This funding opportunity supports research projects that include clinical trials aimed at improving health outcomes, targeting a wide range of eligible applicants such as universities, nonprofits, and for-profit organizations.

This grant provides funding for short courses that aim to enhance research skills in using cognitive data to study aging and Alzheimer's disease across different countries, ultimately improving health outcomes and informing policies.

The purpose of this Notice of Funding Opportunity (NOFO) is to support collaborative, transdisciplinary, translational research projects which advance exceptionally promising, chemically complex botanical and other natural products relevant to dietary supplements towards highly informative clinical trials of their effects on quantitative, objective measures of human resilience. Dynamic, synergistic interactions among the range of experts required to ensure rigor in all aspects of this research will be supported by a multi-PD/PI team collaborating on a single set of integrated specific aims, culminating in data on optimal parameters for a future proposed clinical efficacy trial, as well as the development and validation of other critical knowledge and methods for interpretation of such a trial, such as clinical assessment of the engagement of an outcome-relevant target. Enhancing workforce and institutional capacity to conduct future rigorous, transdisciplinary research on chemically complex natural products must be built into the plans for research and for enhancing diverse perspectives. Achievement of the RM1 specific aims is expected to provide a strong foundation for a future highly informative clinical efficacy trial of the effects on resilience of a chemically complex natural product.This NOFO is one component of the Consortium Advancing Research on Botanicals and Other Natural Products (CARBON) Program. Other components of this Program include RFA-AT-24-008, Leveraging Data at Scale to Understand Natural Product Impacts on Whole Person Health (R01) and RFA-AT-24-007, Limited Competition: Research Resource for Natural Product Nuclear Magnetic Resonance Data (R24).

The purpose of this notice of funding opportunity (NOFO) is to support research that 1) defines associations between variations in human leukocyte antigen (HLA) and killer cell immunoglobulin-like receptor (KIR) genetic regions and immune-mediated diseases, 2) elucidates mechanisms underlying these associations with the goal of advancing therapeutic opportunities, and/or 3) validates association data in order to improve the predictive power of clinical disease screening.

This funding opportunity is designed to strengthen health informatics capabilities in PEPFAR-supported countries by developing a skilled workforce and enhancing digital health systems to combat HIV/AIDS and tuberculosis effectively.

This funding opportunity supports higher education institutions, nonprofit organizations, for-profit organizations, and local governments in establishing a Coordinating Center to implement and evaluate population genomic screening in primary care, focusing on diverse communities and actionable genetic conditions.

This funding opportunity is designed for U.S. academic institutions with specialized mining programs to develop innovative technologies and research that improve the safety and effectiveness of underground mine evacuations during emergencies.

This funding opportunity supports U.S. institutions conducting clinical trials on innovative regenerative medicine therapies using adult stem cells, focusing on extending research from previously funded projects.

The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) intend to publish a Notice of Funding Opportunity (NOFO) to solicit applications for large single or multisite clinical trials within the mission area of the institute. The NOFO is expected to be published in Spring 2024 with an expected application due date in Summer 2024. Only New, Resubmission and Revision applications will be eligible. This NOFO will utilize the UG3/UH3 phased cooperative agreement activity code. A UG3 milestone plan is required. Details of the planned NOFO are provided below.